CIK 0001088856 · Large accelerated filer
CORCEPT THERAPEUTICS INC
Sign in to watch- Ticker
- CORT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770487658
- Phone
- 650.688.8803
- Business address
- 101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,067,988
- in 15 filings, $36.6M under 10b5-1 plans
Net −$41,067,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-07-17 | Guyer William Chief Development Officer | Option exercise · Stock option (right to buy) 10b5-1 | −4,379 | 385,521 | ||
| 2025-07-10 | Swisher Daniel N JR Director | Option exercise 10b5-1 | +2,200 | $14.08 | $31K | 2,200 |
| 2025-07-10 | Swisher Daniel N JR Director | Sale 10b5-1 | −2,200 | $71.08 | $156K | 0 |
| 2025-07-10 | Swisher Daniel N JR Director | Option exercise · Stock option (right to buy) 10b5-1 | −2,200 | 7,700 | ||
| 2025-07-03 | Maduck Sean See Remarks | Gift 10b5-1 | −40,000 | 59,717 | ||
| 2025-07-03 | Maduck Sean See Remarks | Other acquisition 10b5-1 | +40,000 | 40,000 | ||
| 2025-07-01 | Guyer William Chief Development Officer | Option exercise 10b5-1 | +100 | $21.65 | $2K | 5,587 |
| 2025-07-01 | Guyer William Chief Development Officer | Sale 10b5-1 | −100 | $73.51 | $7K | 5,487 |
| 2025-07-01 | Guyer William Chief Development Officer | Option exercise · Stock option (right to buy) 10b5-1 | −100 | 389,900 | ||
| 2025-07-01 | Lyon Joseph Douglas See Remarks | Option exercise 10b5-1 | +100 | $13.56 | $1K | 10,166 |
| 2025-07-01 | Lyon Joseph Douglas See Remarks | Sale 10b5-1 | −100 | $73.51 | $7K | 10,066 |
| 2025-07-01 | Lyon Joseph Douglas See Remarks | Option exercise · Stock option (right to buy) 10b5-1 | −100 | 41,471 | ||
| 2025-07-01 | Maduck Sean See Remarks | Option exercise 10b5-1 | +205 | $5.05 | $1K | 17,910 |
| 2025-07-01 | Maduck Sean See Remarks | Sale 10b5-1 | −205 | $73.45 | $15K | 17,705 |
| 2025-07-01 | Maduck Sean See Remarks | Option exercise · Stock option (right to buy) 10b5-1 | −205 | 61,781 | ||
| 2025-06-16 | Robb Gary Charles Chief Business Officer | Sale | −3,185 | $70.77 | $225K | 13,364 |
| 2025-06-12 | Maduck Sean See Remarks | Gift 10b5-1 | −10,024 | 7,681 | ||
| 2025-06-12 | Maduck Sean See Remarks | Other acquisition 10b5-1 | +10,024 | 99,717 | ||
| 2025-06-10 | BAKER G LEONARD JR Director | Grant or award · Stock Option (Right To Buy) | +15,000 | 15,000 | ||
| 2025-06-10 | Cannon Gillian Director | Grant or award · Stock option (right to buy) | +15,000 | 15,000 |
Page 23 of 61 · 1,220 trades